Cadrenal Therapeutics Inc... (CVKD)
NASDAQ: CVKD
· Real-Time Price · USD
12.60
-0.32 (-2.48%)
At close: Aug 15, 2025, 3:59 PM
12.69
0.71%
After-hours: Aug 15, 2025, 06:19 PM EDT
Cadrenal Therapeutics Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Mar 31, 2022 |
Net Income | -3.67M | -3.85M | -4.19M | -2.41M | -2.39M | -1.66M | -1.14M | -1.04M | -1M | -5.17M | -5.01M | -1.03M | -176.65K |
Depreciation & Amortization | 401.00 | 5.52K | 407.00 | 406.00 | 470.00 | 597.00 | 597.00 | 597.00 | 596.00 | 190.00 | 760.00 | 506.00 | n/a |
Stock-Based Compensation | 592.64K | 548.76K | 763.21K | 299.98K | 193.12K | 162.73K | 103.11K | 153.07K | 167.8K | 286.4K | n/a | n/a | n/a |
Other Working Capital | 425.61K | -1.15M | 627.34K | 169.02K | 311.11K | -569.37K | 320.22K | 191.4K | 80.64K | -210.37K | 257.08K | n/a | 113.78K |
Other Non-Cash Items | n/a | n/a | -35 | 240.16K | -165.19K | -69.23K | 78.67K | 89.00 | 90.00 | 3.97M | 4.27M | 1.03M | 4.05K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -78.65K | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 48.44K | -1.36M | 1.63M | -333.94K | 670.25K | -336.31K | 345.88K | 254.92K | 39.21K | -495.7K | 353.75K | n/a | 128.9K |
Operating Cash Flow | -3.03M | -4.65M | -1.79M | -2.2M | -1.53M | -1.84M | -694.45K | -627.78K | -795.31K | -1.41M | -290.22K | 1.01K | -43.7K |
Capital Expenditures | 3.25K | -3.25K | -6.54K | n/a | n/a | n/a | -3.25K | n/a | n/a | n/a | 2.28K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 3.25K | n/a | -3.25K | n/a | -2.28K | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 3.25K | -3.25K | -6.54K | n/a | n/a | n/a | n/a | n/a | -3.25K | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 498.54K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 3.84M | n/a | n/a | 298.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 1.26M | 1.97M | 7.45M | 1.53M | n/a | 298.00 | -12.5K | 6.51M | -23.18K | 5.41M | 219.72K | n/a | 506.04K |
Net Cash Flow | -1.77M | -2.68M | 5.65M | -673.27K | -1.53M | -1.84M | -706.95K | 5.88M | -798.56K | 4M | -70.5K | 43.44K | 462.34K |
Free Cash Flow | -3.02M | -4.65M | -1.8M | -2.2M | -1.53M | -1.84M | -697.7K | -627.78K | -795.31K | -1.41M | -287.94K | 1.01K | -43.7K |